<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Inhibitors of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> may regulate tissue differentiation and promote cell survival in <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A new <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inhibitor of the bcl-2 gene family, bcl-X(L), was recently found in some types human <z:hpo ids='HP_0002664'>neoplasia</z:hpo> but not in <z:mpath ids='MPATH_458'>normal</z:mpath> tissue </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated bcl-X(L) expression in 419 cases of <z:mpath ids='MPATH_458'>normal</z:mpath> and neoplastic lymphoid lesions using immunohistochemistry with the monoclonal antibody bcl-X(L) (YTH-2H12) </plain></SENT>
<SENT sid="3" pm="."><plain>Ninety-four percent (141/150) of classic <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) were positive for bcl-X(L) with strong intensity in most Reed-Sternberg (RS) cells </plain></SENT>
<SENT sid="4" pm="."><plain>Forty-eight percent (38/80) of nodular lymphocyte predominance (LPHD) were positive </plain></SENT>
<SENT sid="5" pm="."><plain>In the non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL), bcl-X(L) was expressed in a low percentage of cases (&lt; 20%), with the exception of follicle center <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, grade III/III (78%) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> reactive hyperplastic lesions were negative for bcl-X(L) </plain></SENT>
<SENT sid="7" pm="."><plain>RS cells, which expressed bcl-X(L), were not labeled by terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labeling (TUNEL) </plain></SENT>
<SENT sid="8" pm="."><plain>We found RS cells expressing bcl-X(L) were absent of DNA fragmentation (<z:mpath ids='MPATH_3'>apoptosis</z:mpath>) </plain></SENT>
<SENT sid="9" pm="."><plain>Our data provide evidence that bcl-X(L) is abnormally expressed in the RS cells of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> and some types of NHL raising speculation that inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> may be important in the pathogenesis of <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, specifically <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, the previously reported correlation between bcl-X(L) and Epstein-Barr virus expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> was not supported by this study </plain></SENT>
</text></document>